【摘要】 目的探讨脑利钠肽(BNP)在不同阶段COPD合并慢性肺源性心脏病中的诊断意义。方法测定单纯COPD组(A组)、COPD合并肺心病急性加重期组(B组),COPD合并肺心病缓解期组(C组)各40例,检测各组血浆BNP水平,并对三组进行相关分析;结果 BNP值在B组高于C组,高于A组,且两两之间差异都有统计学意义。结论 BNP在区分COPD是否合并肺心病及判定肺心病发病时期具有一定的临床意义。更多还原

【Abstract】 Objective To investigate the diagnostic significance of serum BNP test in the determination of different stages of COPD patients complicated with pulmonary heart disease.Methods 120 patients were evenly divided into 3 groups: the group A(COPD),the group B(COPD complicated with acute exacerbation of pulmonary heart disease),the group C(COPD complicated with cor pulmonale at remission stage).The level of serum BNP was examined and analyzed among the three groups.Results The level of serum BNP was the highest in the group B,and the difference among the three groups had statistical significance.Conclusion The level of BNP has a certain clinical significance in the determination of different stages of COPD patients complicated with pulmonary heart disease.更多还原